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Abstract

Thujone is a natural compound found in plants such as “wormwood” and “sage” and
it’s also found in the alcoholic drink “Absinthe”. Thujone has been suggested as a
neurotoxic compound and reported to modulate GABAA receptors. In this study, we
investigated the pharmacology of Thujone on nicotinic receptors expressed in Xenopus
oocytes using the two electrode voltage clamp method. Thujone (100µM) caused an
80% inhibition of Acetylcholine (ACh) induced currents in human α7-nAChRs
expressed in frog oocytes while only 30% inhibition currents in α4β2 expressed
oocytes and no effect on α3β4, α3β2 and α4β4 nAChRs. The mechanisms of Thujone
effect on the α7-nAChR were further investigated and found to be independent of
membrane potential and did not compete with ACh. Furthermore, Thujone did not
affect the activity of endogenous Ca2+ dependent Cl- channels. In conclusion, Thujone
inhibits human nAChRs with different potencies.
Keywords: Thujone, Xenopus oocytes, nicotinic acetylcholine receptors.
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)Title and Abstract (in Arabic

أثارالمركب ثوجون على صفات مستقبالت االسيتايل كولين النيكوتينية
ملخص
تم العثور على مركب طبيعي ثوجون في النباتات مثل " مرارة " و " حكيم " وانها وجدت أيضا في المشروبات
الكحولية "  . " Absintheوقد اقترح أن ثوجون قد يؤثر على األعاا وهذا بعمله على مستقبالت GABAA
 .في هذه الدراسة ،نحن نقوم بالتحقيق في صفات ثوجون على مستقبالت االسيتايل كولين النيكوتينية المكونة من
ألفا  7و المستنسخة في بويضات ضفادع ( )Xenopusو ذالك باستخدام تقنية تثبيت الجهد الكهربائي في البويضة
باستخدام قطبين كهربائين .ثوجون (  ) μM100تسبب في تثبيط  ٪ 80من حجم التيارهت االصلية .في حين أن
ثوجون قام فقط بتثبيط  ٪ 30من حجم التيار األصلي على بويضات مستنسخة بقنوات االسيتيل كولين النيكوتينية
المكونة من  α4β2كما ليس له تأثير على بويضات مستنسخة بقنوات االسيتيل كولين α4β4 ،α3β2 ،α3β4
 .و عند مزيد التحقيق في صفات ثوجون على مستقبالت االسيتايل كولين النيكوتينية المكونة من ألفا  7وجدت
أن التثبيت ليس له عالقة بالتيار الكهربائي لدى الخلية وغشاء المحتملة  ،ولم يتنافس مع أدن تشافيز  .وعالوة
على ذلك  ،ثوجون لم يؤثر على قنوات الكلوريد المعتمدة على الكالسيوم و المتواجدة في غشاء البويضة الذاتية.
وفي الختام ،ثوجون لديه فعالية وصفات ذاتية مختلفة على مستقبالت االسيتايل كولين النيكوتينية.

مفاهيم البحث الرئيسية :ثوجون  ،البويضات لضفادع ) ،(Xenopusمستقبالت األستيل كولين النيكوتينية .

ix

Acknowledgments

I would like to take this chance and deeply express my gratitude to thank and
appreciate everyone that helped me and truly inspired me to pursuit my Master’s
degree and help motivate me along the way.
First of all, I would like to thank my kind and understanding supervisor,
Professor Murat Oz in the Department of Pharmacology, College of Medicine and
Health Science. I really appreciate his support and guidance and his undivided
attention. He has guided me along the way and inspired me to become passionate about
seeking science and knowledge.
I would like to appreciate the Chairman of Department of Pharmacology,
College of Medicine and Health Science Professor. Salim Bastaki for his support and
enthusiasm and Dr. Samir Attoub the coordinator for the post graduate studies for all
his support and feedback.
I want to express my graduation to all my doctors and professors in the
pharmacology department who have been very keen on asking me all the right
questions and to insure my proper education.
Furthermore, I would like to thank the external evaluator Dr. Imad Damaj from
Virginia Commonwealth University for coming all the way to Alain to review and
correct my thesis and for his thoughtful remarks.
I must also appreciate all the guidance and support I have received from Dr.
Syed Muhammad Nurulain, Medical Research Specialist for all his dedicated hard to
support me along the way and to teach me to perform admirably in the laboratory.
I would like to thank all my friends and colleagues for their support and advice
Ali Saad, Eglal Mahgoub, Ahlam Said and Aisha Alkatbi and a special thanks to my
dear friend Mohamed Omer Mahgoub for he is one the reasons why I chose this
program.

x

Dedication

I dedicate this to my beloved family and my lovely parents firstly to my mother for
raising me to become the man I am today and for loving me the way she did and
especially to my beloved Father for he is a professor of Analytical Chemistry and he
has always supported me to fulfill my goals weather emotionally or financially, I hope
by this I can make you proud as I am a proud son.
Finally, I would like to thank my sisters and brothers for their encouragement,
without them I will not be who I am today.

xi

Table of Contents
Title ……………………………..…………………………………………..……….. i
Declaration of Original Work …….……………………………………..………...…ii
Copyright …………………….………………………………………..…………….iii
Advisory Committee ………….……………………………………..……………... iv
Approval of the Master Thesis ……..………….…………………..…………………v
Abstract…………………………..……………………………….………………...vii
Title and Abstract (in Arabic) ……..……………………….…..…………...……...viii
Acknowledgments ……….…………………………………..…………………..….ix
Dedication ……………….………….………………………..………………………x
Table of Contents ……………..………..…………………..…………………......... xi
List of Tables …………………………………………...…………………….…....xiii
List of Figures ………………………………………...……………………........... xiv
Glossary ……………………………………………...………………………......... xv
Chapter 1: Introduction ……...……………………...……………….……..…..…… 1
1.1 Artemisia absinthium L (Wormwood) ……..……………..…………..……...1
1.2 The Plant Sage Lamiaceae ……………………………..…..…………….…..2
1.2.1
Dalmatian Sage ………………………………..…………………..…2
1.2.2
Spanish Sage ……………………….……….………………………..3
1.2.3
Greek Sage ……………………………..………………………….....3
1.2.4
Cretan Sage ………………………………..…………………………3
1.3 Thuja C. species (Red cedar) …………………………….…………………..4
1.4 Monoterpene Ketones ………………………………………………………..5
1.5 Thujone ………………………………………………………………...….....6
1.5.1
Clinical applications of Thujone herbs ………………………..……..7
1.5.2
Thujone toxicity studies …………………………………….……......8
1.5.3
Molecular and cellular mechanisms of Thujone ………….…….…...10
1.5.3.1 The effect of Thujone on Ligand Gated Ion Channels.......…….…....11
1.5.3.2 The effect of Thujone on G Protein Coupled receptors……………....13
1.6 Cholinergic system ………………………………………………………….15
1.7 Cholinergic receptors “Cholinoceptors” …………………………...….…....18
1.7.1
Muscarinic receptors ………………………………………………..19
1.7.2
Nicotinic receptors ….……………………………………...…..…...20
1.8 Neuronal Nicotinic receptors …………….…………………………...….…22
Chapter 2: Aims and Objectives ………………………….….……….……………..24
Chapter 3: Materials and Methods ………………….…………………..…...……...25

xii

3.1 Materials ………………………………….……...…...…………………….25
3.1.1
Chemicals ………….………………..………….………...………...25
3.2 Female Xenopus laevis frogs …………….……………………...………….27
3.2.1
Experimental configuration ……..……………………....………….28
3.2.2
Other material used …………………..………...……….…………..31
3.3 Methods …………………………………...………..…………….………...33
3.3.1
Preparation of Modified Barths Solution (MBS) ……..……..………33
3.3.2
Preparation of Storage solution of the oocytes …………..…..………34
3.3.3
Preparation of the Frogs Ringer Solution (ND96)…………….……..35
3.3.4
Isolation of Oocytes from Xenopus Laevis ………..…………..…….36
3.3.5
Oocyte preparation …………………………...……………………..37
3.3.6
Ion channels endogenously expressed in the oocytes …………...…..38
3.3.7
Advantages and disadvantages of oocytes expression system …....…39
3.3.7.1 Advantages …………………………………………...…………….39
3.3.7.2 Disadvantages ………………………………...…………………….39
3.4 Synthesis of cRNA ………………………………………………………….39
3.4.1
Microinjection of cRNA……………………...….……………….....40
3.4.2
Drug preparation ……………………………...….………………....42
3.5 Electrophysiological recording …………………………...……………...…42
3.6 Tested electrophysiological parameters.……………………….……………44
3.6.1
Concentration response curves.……………..…….……...…………44
3.6.2
Competitive and non-competitive inhibition.…….………….………45
3.6.3
Voltage dependency of drug inhibition…….....….…...….…......…...45
3.6.4
Effect of Ca2+ on drug action……………………..………………….45
3.7 Statistical data analysis …………..……………………….…………………46
Chapter 4: Results ………………………………………………..…...…………….47
4.1 Effects of ACh and α-bungaratoxin on α7 nAChR……….........…………….47
4.2 Time and Concentration effects of Thujone on α7 nAChR…....….…………49
4.3 Effects of α-Thujone on endogenous Ca2+ dependent Cl- Channels and
voltage dependence………………………………………………….............51
4.4 Non-competitive effects of α-Thujone on α7 nAChR……….…..………..…54
4.5 Effects of Thujone Sterioisomers on α7 nAChR…………….....……………55
4.6 Effects of Thujone on different nAChRs……………………….……..……..56
Chapter 5: Discussion …………………………………………...……...…………...57
Chapter 6: Conclusion ………………………………………..…..…..……………..61
6.1 Limitations and Future directions……………….……………….…….....…61
Bibliography………...……………………………………………...……………….62

xiii

List of Tables
Table 3.1:

Chemicals …………………………………………………………...25

Table 3.2:

Components of the Two-electrode voltage clamp ...............................29

Table 3.3:

Other devices and materials …………….………………………...…31

Table 3.4:

MBS Solution ……………………………………………………….33

Table 3.5:

Oocyte storage solution ……………………………………………..34

Table 3.6:

Frogs Ringer Solution (ND96) ……………………..……………….35

xiv

List of Figures

Figure 1.1:

Artemisia absinthium L (wormwood)………………………………...1

Figure 1.2:

Salvia officinalis L. …………………………………....……………...3

Figure 1.3:

Thuja occidentalis L …………...………………………..……………4

Figure 1.4:

Structures of monoterpene aldehydes and ketones in essential oils
………………………….………………………………..…………...5

Figure 1.5:
Figure 1.6:
Figure 1.7:
Figure 1.8:

Two dia-stereoisomers of Thujone ………………….……...…...…...6
Ligand gated ion channels ………………………….………...…….11
GPCR Signal transduction ………………………….……………….14
Summary of synthesis and release of Acetylcholine from cholinergic
neuron. AcCoA …………….…………………….………………….16
Summary of the Ch1-Ch8 neurons………………….……………….18
Muscarinic receptors and their signal transduction ……..…………...20
Structure of Nicotinic acetylcholine receptors and nomenclature…....21
Neuronal nicotinic acetylcholine receptors …………………….……23
African clawed female Xenopus laevis frogs …………………...…...28
Two-electrode voltage clamp ……………………………………….29
Oocyte perfusion chamber schematic diagram ...................................31

Figure 1.9:
Figure 1.10:
Figure 1.11:
Figure 1.12:
Figure 3.1:
Figure 3.2:
Figure 3.3:
Figure 3.4:

Two oocyte containing ovaries in different stages of development
……………………………………………………………………….37

Figure 3.5:

Individual oocyte isolated from Xenopus laevis frog after treatment
with collagenase …………………………………………………….38
Micro injector (Nano-injector) and dissecting microscope ……....…41

Figure 3.6:
Figure 3.7:
Figure 4.1:
Figure 4.2:
Figure 4.3:
Figure 4.4:
Figure 4.5:

Figure 4.6:

Illustration of electrical circuitry connecting oocytes to the recording
set-up ………………………………………………….…………….43
Control experiments demonstrating the functional characterization of
ACh induced currents ………………………………….…………....48
Effects of Thujone on α7 nAChR ………………….………………..50
Effects of α-Thujone on endogenous Ca2+ dependent Cl- Channels and
voltage dependence. …………………………...……………………53
Concentration response curves for α-Thujone during increasing
concentrations of ACh ………………………….………...…………54
Percent of Inhibition of α-Thujone and αβ-Thujone on human α7nAChRs induced currents with 100 µM Acetylcholine
……………………………………………………………...………..55
Percent of inhibition of 100 µM α-Thujone co-applied with 100 µM
ACh
on
different
nAChRs
induced
oocyte
currents
…………………………………………….…………………………56

xv

Glossary

5-HT

Serotonin or 5-hydroxytryptamine

ACC

Antibody Dependent Complement Mediated
Cytotoxicity

AcCoA

Acetyl Coenzyme A

ACh

Acetylcholine

AChE

Acetylcholineesterase

AD

Alzheimer’s Disease

ADCC

Antibody Dependent Cellular Cytotoxicity

BAPTA

(1,2-bis (o-aminophenoxy) ethane-N,N,N’,N’tetraacetic acid)

CNS

Central Nervous System

CTL

Cytotoxic T lumphocyte

DLA

Daltons Lymphoma Ascites

EMA

European Medicines Agency

GABA

Gamma γ-Aminobutyric Acid

GPCR

G-Protein Coupled Receptors

Hb-IPN

Habenulo-interpeduncular Pathway

HEK

Human Embryonic Kidney cells

IL-2

Interleukin 2

INF-γ

Interferon Gamma

LGIC

Ligand-Gated Ion Channels

mAChRs

Muscarinic Acetylcholine Receptors

MBS

Modified Barths Solution

MG

Myasthenia Gravis

mIPSC

Miniature Inhibitory Postsynaptic Currents

NA

Noradrenaline or Norepinephrine

nAChRs

Nicotinic Acetylcholine Receptors

NB

Nucleus Basalis

xvi

NK

Natural Killer Cell

NOEL

No Observed Effect Level

NTP

National Toxicology Program

PNS

Peripheral Nervous System

SOC

Store-operated Ca2+ Channels

TEVC

Two Electrode Voltage Clamp

VGCCs

Voltage Gated Ca2+ Channels

VGIC

Voltage-Gated Ion Channels

1

Chapter 1: Introduction
1.1 Artemisia absinthium L (Wormwood)
The Artemisia Absinthium shown in Figure 1.1, named after the Roman “goddess
Artemis” also called “wormwood”, is a well-known herb used for medicine and
culinary purposes over many centuries. It comes from the family called “Asteraceae”
that has 22 different Artemisia species such as: Artemisia vulgaris, Artemisia
arbotanum and Artemisia santonicum. It was also given the name “wormwood” due
to its bitterness and strong taste and it has been included in the alcoholic beverage
“Absinthe” which means undrinkable. (Belhattab, Amor, Barroso, Pedro, &
Figueiredo, 2014; Tobyn, Denham, & Whitelegg, 2011)

Figure 1.1: Artemisia absinthium L (wormwood) (Tobyn et al, 2011)
Since the ancient Egyptian times (460-377 B.C.), wormwood extracts have been
used in the treatment of menstrual pain and rheumatism (Lachenmeier, 2010). During
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the 18th century alcoholic wormwood extracts were produced and in the beginning of
the 19th century, the alcoholic distillates of Absinthe and similar drinks were produced
on a larger scale in Europe. (Baydar, Sangun, Erbas, & Kara, 2013; Lachenmeier,
2010). “Absinthe” also named “the green fairy, Green Muse and Green Goddess”
became a very popular drink especially in France among many artists such as: Vincent
van Gogh, Paul Verlaine, Pablo Picasso, Charles Baudlaire and Oscar Wilde.
Absinthe is a highly alcoholic beverage (45-75%) and it mostly contains essential oil
extracts from different herbs such as: wormwood (Artemisia absinthium), peppermint
(Mentha piperita), fennel seed (Foeniculum vulgare) and angelica (Angelica
archangelica) (Lachenmeier, 2010; Dawidowicz and Dybowski, 2012).
1.2 The plant Sage Lamiaceae
The plant Sage of the family Lamiaceae also called “Labiateae” is made of about
2500 different species with the essential oils as the major component. The Sage herb
produces its highest content of Thujone during the late autumn season. The Sage can
also be called the Salvia herb and include the following:
1.2.1

Dalmatian Sage: Extracts of the dried leaves of this plant contains

Salvia officinalis, which can be found all over Europe making it the most widely
used sage, mainly due to its high content of Thujone reaching up to 65%, 1,8ceniole up to 22% and camphor up to 38% of the total oil content as in Figure
1.2.
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Figure 1.2: Salvia officinalis L. (Picture taken from Wikipedia on 21/12/2014)
1.2.2

Spanish Sage: As its name implies it is produced in Spain from the

shrubs of the plant named Salvia lavandulifolia vahl. This plant has a
considerably low content of Thujone of 1.3%. However, it has very high contents
of 1,8-ceniole and camphor of the total oil (56% and 37%, respectively).
1.2.3

Greek Sage: Salvia fruticosa miller has the highest contents of 1,8-

ceniole of 66% of the total oil and much lower concentrations of Thujone and
camphor.
1.2.4

Cretan Sage: Salvia pomifera has a high Thujone content between

58%-83% of the total oil content with minimum camphor and 1,8-ceniole
quantities. It’s found mainly in Turkey and Greece (Badawy & Abdelgaleil,
2014; Baydar et al., 2013; Kokkini, Karousou, & Hanlidou, 2003; Lachenmeier,
2010; Tobyn et al., 2011).
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1.3 Thuja C. species (Red cedar)
This plant comes from the family Cupressacaea and it is subdivided into two
main species; First is Thuja occidentalis shown in Figure 1.3, also called the
“Eastern Abrovitae” or the “Atlantic red cedar” while the second is the Thuja plicata
donn which is called the “Western Abrovitae” or the “Pacific red cedar”. These two
subdivisions contain high amounts of Thujone, 50-52 % of the total oil content for
Thuja occidentalis and 54-63% of the total oil content in the Thuja plicata donn.
(Bouajaj et al., 2013; Tsiri et al., 2009; Zhang, Schneidmiller, & Hoover, 2013)

Figure 1.3: Thuja occidentalis L. (picture taken from Wikipedia on 21/12/2014)

5

1.4 Monoterpene Ketones
Thujone is a monoterpene ketone found as one of the main constituent’s (almost
90% of total oil) in the essential oils of different kinds of plants. The essential oils are
the lipophilic extracts or mixtures that are produced after the plant has been processed
by different methods such as distillation. The monoterpenes are composed of 10
carbon atoms with at least one double bond derived from two isoprene subunits (2methyl-1, 3-butadiene) that has a molecular formula of (C5H8)n (n referring to the
isoprene units). An example of major essential oil families are: Asteraceae, Apiaceae,
Lamiaceae, Pinaceae and Rutaceae. Monoterpenes are grouped into regular which is
more common, and irregular such as those found in the family Astraceae e.g.
Chrysanthemic acid. The regular monoterpenes are subdivided into ketones, alcohols,
aldehydes and ethers such as those in the Figure 1.4 below. (Akhgar, Rajaei, &
Alizadeh-Saljoughi, 2013; Aldred, Buck, & Vall, 2009; Amri et al., 2013; Badawy &
Abdelgaleil, 2014; Belhattab et al., 2014; Lachenmeier, 2010)

Figure 1.4: Structures of monoterpene aldehydes and ketones in essential oils (taken
from Hall et al., 2004)
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1.5 Thujone
Thujone, as previously mentioned, is available in large amounts from different
plants. Thujone is a lipophilic bicyclic monoterpene ketone usually present in nature
in two stereoisomers α-Thujone also called (-)-3-Thujone (CAS No. 546-80-5) and βThujone also named (+)-β-Thujone (CAS No. 471-15-8) as in Figure 1.5 (Oz, Lozon,
Sultan, Yang, & Galadari; Suramya Waidyanatha et al., 2013)

Figure 1.5: Two dia-stereoisomers of Thujone (taken from Waidyanatha et al, 2013)
Thujone has been reported to have a neurotoxic effect in various earlier studies
(Hold, Sirisoma, Ikeda, Narahashi, & Casida, 2000; Pelkonen, Abass, & Wiesner,
2013; Polatoglu, Karakoc, & Goren, 2013; S. Waidyanatha et al., 2013). It has been
proposed that Thujone intake causes mental deterioration and “Absinthism” which is
manifested by hallucinations, depression and psychotic symptoms. Although large
quantities of Absinthe were required for Absinthism to occur, prolonged exposure to
Thujone has been reported to lead to neurotoxic effects similar to those seen in
Absinthism (Czyzewska & Mozrzymas, 2013; Lachenmeier, Emmert, Kuballa, &
Sartor, 2006; Lachenmeier & Uebelacker, 2010).
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The popularity of Absinthe declined when it was associated with several psychotic
effects, seizures, hallucinations, or mental prostration; all of which were summarized
under the term Absinthism. In particular, the monoterpene Thujone was considered
the active ingredient of absinthe. As a consequence, Absinthe was banned in Belgium
in 1905, and soon after by Switzerland (1908), USA (1912), Italy (1913), France
(1915), and Germany (1923). After its decline in popularity, Absinthe experienced a
resurrection in 1988, when the European Commission allowed the processing of
Thujone-containing plants to maximal concentration of 35 mg/ml in alcoholic spirits
(European Council, 1988). Consequently, in recent years, research on Thujone and
Thujone containing products increased significantly (Höld, Sirisoma, & Casida, 2001;
Padosch, Lachenmeier, & Kroner, 2006). For example, it was reported that Thujone
can bind to GABAA receptors, inhibit its function and cause convulsions (Hold et al.,
2000).
1.5.1

Clinical applications of Thujone herbs

Thujone containing herbal products have been demonstrated to show clinically
beneficial effects in the treatment of the acute common cold and cough (Naser,
Bodinet, Tegtmeier, & Lindequist, 2005). It has also been shown that Thujone have
some antibacterial activity against bacteria such as: E. coli, K pneumonia, S Aureus
and P aeruginosa (Tsiri et al., 2009).
The European Medicines Agency (EMA) also mentioned some of the
pharmacological actions of the herb Artemisia absinthium in promoting relief for
gastric dyspepsia. It was also suggested that Thujone has antipyretic, anthelmintic and
analgesic properties. (EMEA/HMPC/234444/2008) The EMA also reported that the
use of the herb Salvia officinalis is indicated for the inhibition of perspiration or
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sweating making the herb antihidrotic. It was also reported that sage extracts have
memory

enhancing

and

gland

secretion

enhancing

effects

(EMA/HMPC/330383/2008)
In an earlier study, Thujone, when administered by intra peritoneal injection to
mice, caused increased plaque forming cells in spleen, increased natural killer cell
(NK) activity, increased total white blood cell (WBC) count, antibody dependent
cellular cytotoxicity (ADCC) and enhanced cytotoxic T lymphocyte generation
(Siveen & Kuttan, 2011). It was proposed that Thujone enhances the release of
cytokines such as interleukin 2 (IL-2) and interferon gamma (IFN-γ). This is
confirmed by the reduction of Dalton’s Lymphoma Ascites (DLA) induced solid
tumor formation through modulation of immune mechanisms (Lachenmeier &
Uebelacker, 2010; Siveen & Kuttan, 2011).
1.5.2

Thujone toxicity studies

Over the years many groups have tested the toxicity profile of Thujone using
different techniques; although most of these techniques were not performed in
humans, animal studies on mice or rats can be used to help understand our human
bodies. In 2010, Lachenmeier et al reported that gavage application of a racemic
mixture of α, β-Thujone to four groups of 20 different weanling rats at doses of 0,
12.5, 15, 50 mg/kg/day for a period of 13 weeks resulted in convulsions at the higher
dose groups. The NOEL (No Observed Effect Level) for males was 12.5 mg/kg/day
and it was not determined for females since convulsions happened early on in the
experiment with the middle dose adjustments. In other experiments four groups of 20
rats received the Thujone by gavage for 6 days a week for a period of 14 weeks with
doses of 0, 5, 10, 20 mg/kg. Results show that 6 male and 9 female rats convulsed
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when given a high concentration of Thujone and 4 rats died due to convulsions. It was
suggested that the NOEL was 5 mg/kg/day for the females and 10 mg/kg/day for the
males (Dawidowicz & Dybowski, 2012; Lachenmeier & Uebelacker, 2010). In
another study, the reported NOEL was 10 mg/kg in males and 5 mg/kg in females
(Pelkonen et al., 2013).
In an earlier study, Rice and Wilson (1976), identified the subcutaneous LD50
(lethal dose in 50 percent of the population) of α-Thujone on mice to be 134 mg/kg
while β-Thujone to be 442 mg/kg. Another single dose toxicity study by PintoSconamiglio (1967) suggested that the intra peritoneal dose of Thujone of 180 mg/kg
body weight in rats would lead to lethal effects and convulsions. (Pelkonen et al.,
2013) However, another study reported that the intra peritoneal LD50 in mice was 45
mg/kg body weight (Hold et al., 2000).
The results of United States NTP (National Toxicology Program) in 2011 indicated
that gavage doses of both α-Thujone and a mixture of α, β-Thujone resulted in
neurotoxicity (represented by showing signs of hyperactivity, tonic-clonic seizures
and tremors) and increased mortality rates on B6C3F1 mice and Fischer 344 rats. The
doses that were given were 0, 1, 3, 10, 30, or 100 mg/kg/day for a period of 14 days.
The study also performed a 3 month toxicity experiment by giving the animals both
α-Thujone and a mixture of α, β-Thujone in doses of 0, 6.25, 12.5, 25, 50 or 100
mg/kg/day for 13 weeks by gavage. The higher dose groups showed a higher seizure
rate along with high mortality rates when compared to the control and lower dose
groups (Suramya Waidyanatha et al., 2013) (Lachenmeier & Uebelacker, 2010;
Pelkonen et al., 2013).
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Chronic toxicity studies were also performed by the NTP by administering low
doses of a racemic mixture of Thujone by gavage for a period of 2 years. The doses
that were given were 0, 3, 6, 12 and 25 mg/kg per day for the B6C3F1 mice and doses
of 0, 12.5, 25 and 50 mg/kg per day for the Fischer 344 rats. Results show increase
mortality and seizures in both groups at the higher doses. They also show increased
non-neoplastic lesions in the spleen and brains of Fischer 344 rats. Lesions were also
present in the kidneys of male rats and in the female’s pituitary glands at the higher
dose groups. The seizure and mortality NOEL for the rats was 12.5 mg/kg per day
and 12 mg/kg per day for the mice (Pelkonen et al., 2013; Suramya Waidyanatha et
al., 2013).
These studies also revealed the carcinogenicity potential for Thujone since there
was significant increase in the female’s B6C3F1 mice micro nucleated erythrocytes
when they were given the racemic mixture for a period of 3 months. It is also worth
mentioning that Fischer F344 rats had an increase in the formation of benign
pheochromocytoma of the adrenal medulla as well as perpetual gland neoplasms in
the males when given high doses (Ashoor et al., 2011; Davis & de Fiebre, 2006;
Pelkonen et al., 2013; Suramya Waidyanatha et al., 2013; Wu, Gao, & Taylor, 2014).
1.5.3

Molecular and Cellular mechanisms of Thujone

As mentioned earlier, Thujone was found to cause neurotoxicity (represented by
showing signs of hyperactivity, tonic-clonic seizures and tremors) and there have been
several in-vivo and in-vitro investigations to clarify the mechanisms underlying the
neurotoxic effects of Thujone.
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1.5.3.1 The effect of Thujone on Ligand Gated Ion Channels
The ligand-gated ion channels allow the passage of ions by means of extracellular
binding of ligands or neurotransmitters like Acetylcholine (ACh). In (Figure 1.6),
Ligand-gated ion channels have been divided into five major families: 1) Cys-loop
superfamily, 2) Glutamate (Glu)-gated family, 3) Adenosine Triphosphate ATP
(Purinergic)-gated family, 4) Transient receptor family (TRP) family and 5) Acidsensitive ion channel (ASIC) family. The Cys-loop superfamily has also been
subdivided into many receptor subtypes including: A) Nicotinic Acetylcholine
Receptors, B) Serotonin type 3 Receptors, C) GABAA and GABAC Receptors, D)
Glycine Receptors and E) Zinc-Gated Ion channels. (Briggs & Gopalakrishnan, 2007;
Imoto, 2004; McGivern & Worley Iii, 2007; Millar & Gotti, 2009; Suppiramaniam,
Abdel-Rahman, Buabeid, & Parameshwaran, 2010).

Figure 1.6: Ligand gated ion channels (picture taken from Nature Reviews)
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The Cys-loop superfamily is composed of a large N-terminal domain where the
agonist will bind at one end and the C-terminus at the other making this adjacent
cysteine pair important for channel gating, four transmembrane α-helices segments
(M1-M4) and a variable intracellular loop between M3 and M4 shown in Figure 1.6.
Some of these channels are excitatory receptors such as nicotinic acetylcholine and
serotonin type 3 (5-HT3) receptors. They permeate mainly cations such as Ca2+ and
Na+ causing depolarization of the membrane. While others are named inhibitory such
as GABAA and glycine receptors, and they selectively permeate anions such as Clcausing hyperpolarization or inhibition of neuronal firing s (Briggs & Gopalakrishnan,
2007; Hold et al., 2000).
In an early study conducted to understand the mechanisms of Thujone action
it was found that this compound acts on dorsal root ganglia of mice by inhibiting
GABAA receptors that are mainly distributed in the central nervous system (CNS)
(Hold et al., 2000). This effect was also seen in the (Hall et al., 2004) experiments
involving Xenopus oocytes injected with α1β2γ2 GABAA receptors. The results of the
study show that Thujone dia-stereoisomers have an inhibitory effect on these
receptors. In another study done recently in cultured hippocampal neurons, αThujone (100 µM) was able to inhibit miniature inhibitory postsynaptic currents
(mIPSC) in patch clamp experiments (Szczot, Czyzewska, Appendino, &
Mozrzymas, 2012); suggesting that Thujone effects the function of GABAA receptors
by down regulating phasic or synaptic GABAA transmission. However, subsequent
studies showed that (Czyzewska & Mozrzymas, 2013) α-Thujone has an inhibitory
effect on the phasic as well as the tonic or extra-synaptic GABAA transmission by its
actions on different subunits of GABAA receptors. It was found that Thujone acted
on α1β2δ receptors with highest potency, suggesting that tonic currents might be
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more sensitive to Thujone than phasic currents (Czyzewska & Mozrzymas, 2013;
Szczot et al., 2012). In another study on GABAA receptors in neonatal chicks, αThujone was able to induce “anxiogenic-like” effects on behavior when administered
centrally; the authors proposed that Thujone reduced the postsynaptic membrane
receptors and caused suppression in stress induced increase of GABAA receptor
recruitment (Höld et al., 2001; Lachenmeier & Uebelacker, 2010; Rivera, Cid,
Zunino, Baiardi, & Salvatierra, 2014).
The effects of Thujone are not limited to GABAA receptors. In patch clamp studies,
Thujone was able to reduce serotonin type 3 receptor (5-HT3) activity by enhancing
the binding of the ligand serotonin and strengthening the channel blocking potency. It
was reported that, Thujone was involved in receptor desensitization in cultured human
embryonic kidney (HEK 293) cells (Deiml et al., 2004; Qiao, Sun, Clare, Werkman,
& Wadman, 2014).
Both, 5-HT3 and GABAA receptors are members of the LGIC family. However,
nicotinic receptors are the prototype for LGIC, and the effects of Thujone on these
receptors are currently unknown.
1.5.3.2 The effect of Thujone on G-Protein Coupled receptors
G-protein coupled receptors also named “7TM receptors” are the largest group of
receptors that have been identified to date with 800 different types. They are the most
common site for drugs and chemicals. They are made of a single polypeptide that has
an intracellular C-terminal domain and an extracellular N-terminal domain between
these two domains consisting of seven hydrophobic trans-membranes (TM1-TM7)
(Figure 1.7). These trans-membrane domains are also linked by intracellular and
extracellular loops. Most GPCRs involve second messenger systems such as GS
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(Stimulatory) and GI (Inhibitory) such as those involved in the binding of α-GTP
which activates or inhibits adenylyl cyclase (AC) which ultimately modulates the
synthesis of the second messenger cyclic adenosine monophosphate (cAMP) and
eventually leads to a biological response (S. P. Alexander et al., 2013; Clark, 2012;
Gotti et al., 1988; Oz, 2006)

Figure 1.7: GPCR Signal transduction (picture taken from Clark, 2012)
Cannabinoid receptors are a member of the GPCR class of receptors. Since
“Absinthsm” has several symptoms (such as cognitive deficits) common with cannabis
toxication, it was initially thought that Thujone modulates cannabinoid receptors.
However, Thujone has failed to evoke responses in Cannabinoid receptors although it
has a low binding affinity for these receptors since it was able to displace the binding
of the agonist [3H]CP55940 with a Ki of 130 µM and Ki of 115 µM at the Cannabinoid
receptor CB1 from rats P2 isolated membranes and CB2 in human isolated tonsil
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membranes expressing the cannabinoid receptors, respectively (Meschler and Howlett,
1999; Gotti and Clementi, 2004). Thus it has been concluded that Thujone does not
evoke cannabinoid receptor responses. (Gotti & Clementi, 2004; Gotti, Fornasari, &
Clementi, 1997; Gotti et al., 1988; Mahgoub et al., 2013; Meschler & Howlett, 1999;
Oz, 2006; Oz, Al Kury, Keun-Hang, Mahgoub, & Galadari, 2014)
1.6 Cholinergic system
The nervous system is a widely studied complex network with many different
structures; it is divided into the central nervous system (CNS) which consists of the
brain and spinal cord and the peripheral nervous system (PNS) which consists of the
neurons outside the brain and spinal cord either named: “afferent” that bring or carry
the signal towards the CNS from the periphery or “efferent” that carry the signal
away from the CNS to the periphery. The “efferent” is also subdivided into
“Somatic” which includes the voluntary neurons involved in motor control; and
“Autonomic” which are involved in the involuntary neurons that control
requirements of the vital functions of the body and everyday unconscious activities
such as breathing and digestion (Clark, 2012; Clarke, 2008a; Cuello, 2009).
Over the past century scientists were able to map most of these systems and the
main neurotransmitters involved in the mechanisms of actions of these systems. Our
focus in this study is the cholinergic system with acetylcholine (ACh) being the most
abundant neurotransmitter involved in the central and peripheral nervous systems. It
is synthesized in the synaptic axon and the neuronal cytoplasm by choline
acetyltranferase enzyme which requires the presence of both acetyl coenzyme A and
choline as substrates. Once formed ACh is stored in synaptic vesicles in the axon.
Membrane depolarization will cause an increase in the intracellular Ca2+ and the
release of the neurotransmitter ACh from the vesicles into the synaptic cleft by
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exocytosis (Figure 1.8). Once released ACh can either bind to receptors on pre or
post-synaptic membranes or get hydrolyzed by the enzyme Acetylcholineesterase
(AChE) into Acetate and Choline which will be taken up by the axon (Clementi,
Fornasari, & Gotti, 2000; Cooper, Bloom, & Roth, 2003; Hendrickson, Guildford,
& Tapper, 2013; Mufson, Counts, & Ginsberg, 2009; Westfall, 2009).

Figure 1.8: Summary of synthesis and release of Acetylcholine from cholinergic
neuron. AcCoA: Acetyl coenzyme A. (picture taken from (Clark, 2012; Clarke,
2008b).
The brain contains several ACh innervations called cholinergic pathways. It has
been shown that ACh is the neurotransmitter at all autonomic ganglionic neurons,
neuromuscular junctions and parasympathetic post-ganglionic synapses (Cooper et
al., 2003; Gotti et al., 2007). In the central nervous system (CNS) the
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neurotransmitter ACh plays a role in several physiological functions such as
learning, attention, motor control and memory through multiple and complex
cholinergic pathways. These cholinergic pathways have been recently mapped
through various immuno-histochemical staining techniques and it has been shown
that these pathways originate from the basal forebrain. Scientists then introduced the
Ch1-Ch4 nomenclature of these cholinergic neurons. Ch1 represents the cholinergic
neurons of the medial septum, Ch2 consist of the diagonal band of Broca also
referred as the “Vertical limb”. Ch3 neurons compromises the “horizontal limb” and
finally, Ch4 nomenclature contains the largest group of cholinergic neurons almost
90% which are in the cells of the nucleus basalis (NB) (Figure 1.9). The nucleus
basalis projects to the cerebral cortex but the cortex doesn’t contain cholinergic
neurons, it receives projections from the limbic, amygdala and paralimbic
projections; thus the term “nucleus basalis” can be referred to the cholinergic and
non-cholinergic components, however, only Ch4 is used in cholinergic innervations.
The second group of cholinergic pathways can be described by their presence in the
upper brain stem projecting from the rostral midbrain to the midpontine level. This
group can also be subdivided into Ch5 mainly in the pedunculopontine nuclei, Ch6
in the lateral dorsal tegmental nucleus connecting to the thalamus. Ch7 neurons
innervate the interpeduncular nucleus in the medial habenula of the epithalamus.
Finally, Ch8 neurons are in the mesopontine region inside the parabigeminal nucleus
innervating the superior colliculus. (Figure 1.9) summarizes these cholinergic
pathways. (Cooper et al., 2003; Cuello, 2009; Gotti & Clementi, 2004; Gotti et al.,
1997; Keverne & Ray, 2005; Mesulam, 2009; Mufson et al., 2009; Oz, Lorke, &
Petroianu, 2009)
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Figure 1.9: Summary of the Ch1-Ch8 neurons. Amg:amygdala, CC: corpus
callosum, Fx: fornix, Hippo: hippocampus, Ext cap: external capsule, IC: internal
capsule, Th: thalamus, SC: superior colliculus, intped nucleus: interpeduncular
nucleus (Taken from: (Mufson et al., 2009).
1.7 Cholinergic receptors “Cholinoceptors”
After acetylcholine has been released into the synaptic cleft, it binds to the
cholinergic receptors either on the pre-synaptic or on the post-synaptic nerve
terminal. There are two different types of “Cholinoceptors”; the muscarinic
“mAChR” and nicotinic receptors “nAChR” with different affinities and efficacies
for ACh. The muscarinic receptors are G-protein coupled receptors and they have
the highest affinity for the alkaloid found in mushrooms called: “Muscarine” and
lower affinities for nicotine. The nicotinic receptors on the other hand have a higher
affinity for nicotine and they are ligand gated ion channels (Clark, 2012; Cuello,
2009; Eaton, Ospina, Rodrıǵ uez, & Eterović, 2004; Keverne & Ray, 2005; Mesulam,
2009).
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1.7.1

Muscarinic receptors

As it was mentioned previously, these receptors are G-protein coupled
receptors and their signal transduction mechanism involves the activation of Gproteins. There are five subtypes of the muscarinic receptors M1-M5 as have been
described by binding studies, gene cloning and pharmacological methods. These
metabotropic receptors are located in almost all organs and tissues which are
innervated by parasympathetic nerves. The M1 is located mainly in the gastric
parietal cells, whereas the M2 receptors are located in smooth muscle cells and
cardiac muscle. M3 receptors are located in exocrine gland, bladder and smooth
muscles. M1, M3 and M5 function by activating Gq leading to activation of
phospholipase C. Hydrolysis of phosphatidylinositol-(4,5)-bisphosphate by
phospholipase C leads to production of diacylglycerol and inositol-(1,4,5)trisphosphate which are second messengers that increase the intracellular Ca2+
levels. On the other hand, M2 and M4 receptors are coupled to inhibitory Gi
protein that will inhibit adenylyl cyclase 2 and increase K+ conductance and
inhibit cyclic adenosine monophosphate cAMP (Figure 1.10). Both of these
mechanisms of action will ultimately lead to a physiological response by the
effector organ (Clark, 2012; Eglen, Choppin, & Watson, 2001; Gotti & Clementi,
2004; Mufson et al., 2009; Paterson & Nordberg, 2000; Westfall, 2009).
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Figure 1.10: Muscarinic receptors and their signal transduction (taken from Eglen et
al., 2001).
1.7.2

Nicotinic receptors

The nAChR is an ionotropic pentameric protein belonging to the Cys-loop
superfamily of ion channel complexes. Other members of the Cys-loop family
include the GABAA, 5-HT3 and glycine receptors. A number of nAChR genes have
been identified that encode a total of 17 subunits (α1-10, β1-4, γ, δ and ε). Each gene
encodes a protein structure of a large N-terminal extracellular domain, an
extracellular C-terminus domain, four α-helixes (M1-M4) and intracellular loop
between M3 and M4 (Figure 1.11). The Acetylcholine binds to a site near the α-helix
where two cysteine tandem residues are located. The “orthosteric” binding site for
ligands is formed by at least three different peptides the α-helix and three different
adjacent subunits (complimentary components). The receptor also contains a binding
site for several compounds with diverse structure that is different from Acetylcholine
and referred to as the allosteric binding site. Both positive and negative allosteric
modulators have a separate binding site on the receptor. Nicotinic receptors assemble
in different combination for example α (2-6) and β (2-4) subunits which influence
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the receptors pharmacology and biophysical properties. The β3 and α5 subunits fail
to produce function when alone or paired; however, they can produce function when
they are expressed as an extra subunit with α and β subunit pairs e.g. α4αβ2β3,
α5α6β2. The α7, α8, and α9 subunits can form homo-oligomers and hetero-oligomers
by adding another subunit such as: α7β2 and α9α10 (Figure 1.11) (S. P. H. Alexander
et al., 2013; Ashoor et al., 2011; Baginskas, Kuraitė, & Kuras, 2015; Davis & de
Fiebre, 2006; Hendrickson et al., 2013; Wu et al., 2014; Zwart, Strotton, Ching,
Astles, & Sher, 2014).

Figure 1.11: Structure of Nicotinic acetylcholine receptors and nomenclature taken
from: (Hendrickson et al., 2013)
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1.8 Neuronal nicotinic receptors
The term “neuronal” implies that these receptors are located in the central nervous
system but not on the peripheral nervous system. The most common receptors which
have been identified to be neuronal in nature are the α7 and α4β2 nicotinic
acetylcholine receptors. They are pentameric in structure which suggests they are
composed of five subunits. The α7 have been associated with cognitive functions
and psychosis, while the α4β2 have been linked with analgesia, tobacco addiction,
learning and memory, although not exclusively. The α7 nicotinic receptor is
“homomeric” which means it is composed of five α7 subunits while the α4β2 is
“heteromeric” and is composed of various ratios of α4 and β2 subunits shown in
(Figure 1.11). The α7 receptor allows entry of Ca2+ while the α4β2 allows the entry
of both Ca2+ and Na+. Mutations of these receptors would result in various forms of
disease such as epilepsy associated with α4β2 neuronal receptor and schizophrenia
associated with α7 mutations (Grady et al., 2010). Up-regulation of the α4β2
receptors that have high affinity to nicotine in smokers was reported after chronic
exposure to nicotine both in- vitro and in-vivo (Gotti et al., 2007). The α4β2 was also
found to be selectively reduced in the cortex of patients with Alzheimer’s disease
(Gotti et al., 2009).
Other Neuronal subtypes have also been identified, for instance, Fowler at al.
(2011) reported that α5 nAChR in the (Hb-IPN) habenulo-interpeduncular pathway
subunit plays an important role in nicotinic dependence in rodents by regulating
nicotine intake and self-administration, this was demonstrated by α5 knockout mice.
α3β2 which is involved in the visual pathway mainly in the retina and its target
tissues the Superior Collicolus (SC) and Lateral Ganiculate Nucleus (LGN). On the
other hand, the α3β4 subtype has been found to be expressed in the pineal gland,
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cerebellum, retina and involved in the release of noradrenaline in the hippocampus
(Gotti et al., 2007). Finally, the α4β4 receptor subtype is expressed in both rat and
chick retinas (Baginskas et al., 2015; Briggs & Gopalakrishnan, 2007; Clementi et
al., 2000; Davis & de Fiebre, 2006; Fowler, Lu, Johnson, Marks, & Kenny, 2011;
Gotti et al., 2009; Gotti et al., 1997; Gotti et al., 2007; Grady et al., 2010; Mufson et
al., 2009; Westfall, 2009)
This project will focus on the α7 receptor subtype while testing the effect of Thujone
on the other α4β2, α3β2, α3β4 and α4β4 nicotinic receptor subtypes (Figure 1.12).

Figure 1.12: Neuronal nicotinic acetylcholine receptors taken from: (Davis & de
Fiebre, 2006).
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Chapter 2: Aims and Objectives
Our laboratory was interested on the effects of different monoterpenes and their
role on nAChRs. Earlier studies revealed the effect of the monoterpene Thujone on
different types of LGICs such as 5-HT3, and GABAA receptors. Since the effects of
Thujone on the function of neuronal nicotinic nAChR is unknown; our main aim was
to investigate the effects of Thujone’s on human neuronal nAChR expressed in
Xenopus oocyte systems. The expression system has the following advantages:
A. Xenopus oocyte expression systems have been widely employed and well
described in many previous studies.
B. We can obtain large number of oocytes with the expression levels necessary to
conduct the experiment.
C. Using the two-electrode voltage clamp method along with the Xenopus oocytes
allows for sensitive yet reliable results and conclusions.
D. The Two-electrode voltage clamp allows for long periods of recording which
is important in long-lasting experiments when using oocyte systems.
The detailed objectives of the experiments are as follows:
A. To investigate the function of Thujone on different neuronal nAChRs
expressed in oocytes using the two-electrode voltage clamp.
B. To investigate the role of intracellular Ca2+ on the effects of Thujone on
neuronal α7 nAChR expressed oocytes.
C. To determine the voltage dependence of Thujone on the α7 nAChR expressed
oocytes.
D. To investigate the binding site of the Thujone on the nAChR.

25

Chapter 3: Materials and Methods
3.1 Materials
3.1.1

Chemicals

All the chemicals (Table 3.1) used in the experiment were purchased from
pharmaceutical companies and they were in research grade purity.
Table 3.1: Chemicals
Molecular
Compounds

Catalogue
Manufacturer

weight

number

Acetylcholine chloride

181.7

Sigma, USA

A6625

BAPTA

764.68

Sigma Aldrich

A-1076

Barium chloride

244.28

BDH, England

R:20-25 S:45

Benzocaine

165.2

Sigma, USA

E-1501

Panreac Quimica,

Lot.

SA

#73917PCP

Roche Diagnostic

Lot.

Corporations, USA

#93211521

Calcium chloride
110.99
anhydrous (CaCl2)
Collagenase – A (from
Clostridium histolyticum

---------

EC.3.4.24.3
Gentamicin reagent

Conc.

Introgen

Cat. Number

solution

50mg/ml

Corporation, China

15750-060

26

HEPES

238.3

Sigma, USA

H3375

Hydrogen chloride (HCL)

37%

Sigma Aldrich, USA

25.814.B

95.22

Sigma, USA

M4880

246.5

Sigma, USA

M9391

Penicillin G

356.4

Sigma, USA

P3032

Potassium chloride (KCL)

74.55

Sigma, USA

P9541

Sodium Chloride (NaCl)

58.4

Sigma, USA

S-3014

84.01

Sigma, USA

S6014
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Amresco, USA

Magnesium chloride
(MgCl2)
Magnesium Sulfate
(MgSO4)

Sodium Bicarbonate
(NaHCO3)
Sodium Hydroxide

Lot.

(NaOH)

#214613010

Sodium Pyruvate

110.04

Sigma Aldrich, USA

P2256

Streptomycin

1457.4

Sigma, USA

S9137

α-Bungarotoxins

~8500

Sigma

T-0195

α-Thujone

152.23

Sigma Aldrich

546-80-5

α,β Thujone

152.23

Sigma Aldrich

76231-76-0
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3.2 Female Xenopus laevis frogs
Electrophysiological recordings from Xenopus laevis frog oocytes have been
commonly used for the investigation of ion channels. Importantly, it was demonstrated
that oocytes have few endogenous channels and they can express foreign proteins
when injected with their respective RNAs (Eaton et al., 2004; Miledi, Parker, &
Sumikawa, 1983; Oz, Spivak, & Lupica, 2004; R. L. Papke & Smith-Maxwell, 2009;
Weber, 1999; Zwart et al., 2014).
Mature African wild type female clawed Xenopus laevis frogs (Figure 3.1) were
obtained from Xenopus Express, Haute-Loire, France and held in reserve in a dechlorinated tap water aquarium (dimensions: 100 cm height, 130 cm length, 66 cm
width) where the water was changed twice per week. The aquarium was placed in an
ambient room temperature of 18 οC and a 12 hour alternating dark and light cycle. The
frogs were fed twice a week with special frog’s food pellets that were also supplied
from Xenopus Express, France. Animal handling and care for all the animals and frogs
were in accordance with institutional guidelines and approved by the animal Ethics
Committee of the College of Medicine and Health Sciences (CMHS) of the United
Arab Emirates University (UAEU).
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Figure 3.1: African clawed female Xenopus laevis frog (taken from: xenopus.com)
3.2.1

Experimental configuration

Two-electrode voltage clamp (TEVC) method was used in the study. This
electrophysiological method clamps the membrane potential by a feedback amplifier
to allow measurement of the current passing through the membrane at clamped
potential. Using this method, the pharmacological properties of membrane proteins
such as ion channels can be investigated. The solutions and drugs were applied by
gravity flow perfusion tubes that were connected directly to the perfusion chamber
where the oocyte was placed as shown in (Figure 3.2).
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Figure 3.2: Two-electrode voltage clamp system
Table 3.2: Components of the Two-electrode voltage clamp system
Device Name

Company of purchase

GeneClamp500B

Axon Instruments, Molecular Devices, Inc, Sunnyvale,

amplifier

CA, USA

Current Head stages

HS-2A Head stage, Gain 10 MG
HS-2A Head stage, Gain 1 MG, Axon instruments,

Voltage Head stages

Magnetic Holding

Molecular devices, Inc, Sunnyvale, CA, USA

Kanetec USA corporation, Bensenville IL, USA

device
Manual
micromanipulator

M33, Märzhäuser, Wetzlar, Germany
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The two electrode voltage clamp consists of the following items:
The Computer hardware for data acquisition (Compaq personal computer, Compaq
Corporation, Wynyard, UK) and analog-digital converter BNC 2081 (National
Instruments, Austin Texas, USA).
Recording chamber illumination used in the recording chamber was supplied by
an optic fiber light source (Figure 3.2) (Fiber life, Hight intensity illuminator series
180, Dolan, Jenner Industries Inc., MA, USA)
A low-power stereo-dissection microscope was employed for visual observation
of the recording chamber (Olympus, Tokyo, Japan, SZ-STB1m 100 AL0.5 Xm
WD186).
The perfusion apparatus consisted of perfusion tubes and bottles containing
extracellular solutions connected to the recording bath by silicon tubing (Cole Parmer
Instrument Company, O.D. 1/8 inch, WALL 1/32 inch and I.D. 1/16 inch, Vernon
Hills, Illonois, USA). The flow rate of perfusion was set to 3 – 5 ml/minute.
Another multichannel perfusion was used for drug applications that consisted of
C-flex tubing (Cole Parmer Instruments Company, O.D. 3/32 inch, WALL 1/32 inch
and I.D.1/32 inch, Vernon Hills, Illinois, USA), 50 ml glass syringes, plastic valves
and coupling devices. The drug application system was based on gravity flow usually
through a micropipette that sits directly 2-3 mm from the perfusion chamber where
the oocyte was placed. On the other end of the recording chamber, a glass suction
tubing was connected directly to the waste disposal flask that was observed and
cleaned routinely (Figure 3.3).
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Figure 3.3: Oocyte perfusion chamber schematic diagram
3.2.2

Other material used

Table 3.3: Other devices and materials
Device or Material

Specifications

Company of Purchase
Drummond Scientific

Automatic Nano-liter
Nanoject
injector

Borosilicate Glass tubing
for microelectrodes

Company, Broomall, PA,
USA

Glass thin-wlled

World Precision

w/filament 1.5 mm,

Instruments, Sarasota, FL,

Catalog #TW150F-4

USA
World Precision

Electrode Holder

---

Instruments, Sarasota, FL,
USA

Magnetic stand and
manipulators

Catalog #7739

Narishige, Tokyo, Japan

32

World Precision
Microfill filling syringe

---

Instruments, Sarasota, FL,
USA
World Precision

Micro-4 Microsyringe

Model UMC4-C

pump controller

Petri Dishes

Instruments, Sarasota, FL,
USA

Catalog #127,60mm

Sterillin, Newport, UK
Corning pH meter,

pH Meter

Model 450

Albany, NY, USA
Stratagene, Santa Clara,

Picofuge

Catalog #400550
CA, USA
Epicenter

RNAase free water in 1.8
Lot #M25/80502
ml Eppendorf tubes

Biotechnologies Madison,
Wisconsin, USA
World Precision

Silver Wires

---

Instruments, Sarasota, FL,
USA
World Precision

Surgical Accessories

Scissors, forceps, scalpels Instruments, Sarasota, FL,
USA

Surgical Sutures

Catgut chrom, reverse
cutting 3/8 circle, USP
4/0, SMI

SMI, DemeTech
Corporation, Miami,
Florida, USA
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Stirrer

Rotomix type 50800,
Model #M50825

Barnstead/thermolyne,
Dubuque, IA, USA

Vertical Puller

Model 700D, heater
adjusted to 48 and
solenoid adjusted to 70 οC
to get resistance of 1-2
MΩ

David Kopf Instruments,
Tujunga, CA, USA

3.3 Methods
3.3.1

Preparation of Modified Barth’s Solution (MBS)

The Modified Barth’s Solution was mainly used during isolation of the oocytes and
will be discussed in later chapters. The composition of MBS is shown in (Table 3.4)
A. Calcium free MBS solution:
Table 3.4: MBS Solution
Concentration

1x (Weight in

10x (Weight in

(mM)

Grams)

Grams)

HEPES

10

2.38

23.8

KCl

1

0.075

0.75

MgSO4

0.8

0.2

2

NaCl

88

5.14

51.4

NaHCO3

2.4

0.2

2

Compound

All the above compounds were dissolved in 1 L of distilled water using a
magnetic stirrer and plate and the pH was adjusted using NaOH to 7.5.
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B . MBS with Calcium:
To prepare this solution, 0.22 g and 2.2 g of CaCl2 was added to the above
components to make stock solutions of 1x and 10x respectively, and they were
dissolved in 1 L of distilled water and the pH was adjusted to 7.5 using NaOH.
3.3.2

Preparation of oocyte storage solution

The storage solution was used to keep the oocytes in incubators at 18ο degrees for
7- 10 days. The composition of the storage solution is shown in (Table 3.5)
Table 3.5: Oocyte storage solution
Compounds

Concentration (mM)

Weight in Grams

CaCl2

2

0.22

Gentamycin

50 mg/L

2 mL

HEPES

10

2.38

KCl

1

0.075

MgSO4

0.8

0.2

NaCl

88

5.14

NaHCO3

2.4

0.2

Penicillin G

100000 U/L

0.019

Sodium Pyruvate

2

0.22

Streptomycin

10 mg/L

0.01

Theophylline

0.5

0.09
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3.3.3

Preparation of Frogs Ringer Solution

The Frogs Ringer solution (ND96) is the working extracellular solution that
was used in the two-electrode voltage clamp system to record the nAChR
mediated ion currents. The composition of the (ND96) is shown in Table 3.6.
Working solutions of 1x were adjusted to pH 7.5 using NaOH before the
experiment.
Table 3.6: Frogs Ringer Solution (ND96)
Concentration

1x (Weight in

10x (Weight in

(mM)

Grams)

Grams)

CaCl2

1.8

0.2

2.0

BaCl2 Or CaCl2

1.8

0.439

4.39

HEPES

5

1.19

11.9

KCl

2

0.15

15

MgCl2

1

0.10

1.0

NaCl

96

5.61

56.1

Compounds
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3.3.4

Isolation of Oocytes from Xenopus Laevis

Once a week, surgery was performed on a frog for oocyte collection. After a 2-3
month recovery period the same frog was used again. Each frog could be used for 4
oocyte collection procedures. The frog was brought in 1 L of cold tap water from the
animal house aquarium where all the frogs are located and securely stored. The frog
was anesthetized by immersion in 0.03% w/v p-aminobenzocaine prepared by
dissolving 300 mg of ethyl p-aminobenzocaine in 15 mL of 70% ethanol which were
immersed in the 1 L of cold tap water which contains the frog. The frog was then
monitored for the unset of anesthesia by pinching of the lower limbs and usually takes
about 5 minutes for the animal to be completely anesthetized. Afterwards, the frog
was placed on a bed of ice to keep its body temperature low during the surgery.
To perform the surgery, all the surgical instruments were sterilized using 70 %
ethanol. A 1.5 cm incision was made using a surgical scalpel through the epidermis
vertically around the right, middle or left of the lower abdominal area. Another deeper
incision was made to the muscle layer where the oocyte lobes are located using
surgical scalpel and scissors. A single lobe or pair of lobes of ovaries containing
oocytes were removed (Figure 3.4) and placed on a petri dish containing Calcium
Free MBS solution. Subsequently, the muscle layer of the abdomen and epidermal
layer were sutured using absorbable Catgut sutures. The frog was then placed in a
container of water and monitored during recovery. All the procedures conducted in
these experiments were approved by the Animal Ethics Committee of College of
Medicine and Health Sciences (CMHS), United Arab Emirates University (UAEU).
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Figure 3.4: Two oocyte containing ovaries in different stages of development taken
from: (http://ibmmsrvlakitu.unibe.ch/sigel/xenopicts.html
3.3.5

Oocyte preparation

After extraction of the oocyte lobes from the frog, the epithelial and follicular layers
on the oocyte surface were removed by treatment with collagenase solution at room
temperature. The collagenase was prepared by dissolving 50 mg of Collagenase, type
A (from Clostridium histolyticum, Roche Diagnostic Corporations, USA) in 25 mL
of Calcium Free MBS solution and transferred in two separate small conical flasks.
The oocytes were placed in two 12.5 mL Collagenase containing flasks for two hours
stirring slowly at 60-80 rotations/minute. At the end of the 1st hour, collagenase
solution was replaced with fresh collagenase solution for the 2nd hour. Subsequently,
the oocytes were washed 6 times using Calcium Free MBS and another 6 times with
Calcium containing MBS solution. Then the oocytes were placed in a Calcium MBS
containing petri dish for oocyte separation and selection. In the selection step, the
oocytes are selected under a dissecting microscope (Bunton Instruments Co Inc,
Model GSZ, Rockville, MD, USA). All the selected oocytes were stage V and VI
which were larger in size with round shape, 1.0 mm - 1.2 mm diameter and clearly
separated dark brown and yellow vegetal animal poles as shown in (Figure 3.5).
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Figure 3.5: Individual oocyte isolated from Xenopus laevis frog after treatment with
collagenase taken from: (http://ibmmsrvlakitu.unibe.ch/sigel/xenopicts.html)
3.3.6

Ion channels endogenously expressed in the oocytes

The Xenopus oocytes can express a wide number of receptors, ion channels
and transporter proteins. Nevertheless, oocytes also contain various endogenously
expressed transporter proteins, ion channels that could interfere with the expression
level and the functional properties of exogenously expressed channels or proteins,
the first type is voltage-gated ion channels (VGIC) which can further include: 1)
Voltage-Gated Ca2+ channels, 2) Inducible Na+ channels, 3) Transient Na+ channels,
4) Amiloride-sensetive N+ channels, 5) Rapidly inactivating K+ channels, 6) Delayed
rectifier ISDN-sensitive K+ channels and 7) Hyper-polarization-activated Clchannels. The second type of endogenously expressed receptors are Ligand-activated
ion channels (LGIC) which include: 1) Ca2+ activated Cl- channels, 2) Na+ channels,
3) K+ channels, 4) Store-operated Ca2+ channels (SOC) and 5) iGluRs containing
endogenous. (Terhag, Cavara, & Hollmann, 2010(Roger L. Papke, Boulter, Patrick,
& Heinemann, 1989; Sands, Costa, & Patrick, 1993; Weber, 1999). Our experiments
were designed to eliminate the contribution of Ca2+ activated Cl- channels mediated
inward currents which will be discussed in later chapters.
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3.3.7

Advantages and disadvantages of oocyte expression system

3.3.7.1 Advantages


Large number of oocytes can be isolated from each frog.



The cells are large in size and can be easily injected with cRNA.



The cells can remain alive for periods up to 2 weeks.

3.3.7.2 Disadvantages


The small number of endogenous expressed proteins can interfere with the
actual current measurements.



The oocytes can deteriorate when exposed to high temperatures so the
recording must be performed at temperatures of 18-23 οC.



Expressed channels can function differently from native cells due to
posttranslational modifications.

3.4 Synthesis of cRNA
The Capped cRNA transcripts were synthesized using mMASSAGE mMACHINE
kit in-vitro (Ambion, Austin, TX, USA) and analyzed by using 1.2% formaldehyde
agarose gel to check the quality and size of the transcripts. This procedure for cDNA
cloning of human nAChRs was provided by Dr. J. Lindstorm (University of
Pennsylvania, PAM, USA). The final concentration synthesized for the human
nAChRs mRNA was 3.7 µg/µL.
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3.4.1

Microinjection of cRNA

The human nAChRs mRNA was kept in 1 µl aliquots in a -80 οC freezer and stored
there for microinjection. After oocyte preparation one aliquot of RNA was transferred
to the laboratory on an ice bucket. The bench was sterilized using 70 % ethanol and
masks and gloves were worn during microinjection to minimize RNAase
contamination. Using a micro-centrifuge the tube was centrifuged at 1200 rpm for 13 minutes and 8 µL of RNAase and DNAase free water was added to the 1 µl cRNA
pellet by the use of a sterile pipette and RNAase DNAase free pipette tips (Denville
Scientific Inc., Metuchen, NJ, USA). During the microinjection only 3-4 µL of diluted
cRNA was required for each batch of oocytes and the remaining cRNA was returned
to the freezer for storage. Microelectrodes used for micro-injection were prepared
with a horizontal puller PIL-1 (World Precision Instruments, Sarasota, FL, USA)
using autoclaved glass capillaries (World Precision Instruments, Sarasota, FL, USA).
The fine needle shaped tips of the glass microelectrodes were broken by applying a
gentle pressure using a fine pair of forceps (Fine Science Tools Inc., Vancouver,
Canada) under a dissecting microscope (Bunton Instruments Co., Rockville, MD,
USA).
Subsequently, the electrode needle was back filled with mineral oil (Sigma, St.
Louis, MO, USA) using a 1 mL glass syringe. The electrode needle was fixed in the
micro-dispenser which was controlled by the micromanipulator. The next step was to
withdraw the 3 µL of diluted cRNA or distilled water drop by the micro-injector and
the mineral oil filled glass. Using the withdrawal knob of the micro-dispenser
controller the mRNA containing aqueous phase was drawn into the needle. This step
was performed under the dissecting microscope to make sure that the tip of the needle
was always at the center of the droplet while drawing the solution (Figure 3.6).
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Low power stereo
microscope

Control box

Micro injector

Figure 3.6: Micro injector (Nano-injector) and dissecting microscope. The oocyte
micro injector unit consisted of a micro injector mounted in the micro-manipulator.
A control box to adjust the amount of solution and a low power dissecting
microscope.
The selected oocytes were placed in a U shaped arrangement in a round meshbottom petri dish that provided mechanical support to the oocytes during the injection.
The oocytes were impaled by the microelectrode needle and 25-30 nL mRNA or
distilled water were injected into each oocyte using the nano-liter injector (microinjector) guided by a Micro-4 micro syringe pump controller. Each petri dish filled
with injected oocytes was then labeled and stored in oocyte storage solution at 18 οC
in a fridge. The oocytes were divided into two groups, the first group contained cells
injected with cRNA encoding human nAChRs and the second group of was the
control which was injected with distilled water. The groups were stored in 18 οC fridge
for 48-72 hours prior to two-electrode clamp experiments to achieve maximal
expression of receptors. The injected oocytes were used for experiments for 7 - 10
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days during which the storage solution was replaced on a daily basis and the cells
with poor quality were removed under the dissecting microscope and were not used
in experiments.
3.4.2

Drug preparation

Stock solutions of the test compounds were all prepared in ND96 solution using
the following formula:
Weight (mg) = (MW) x (Volume (L)) x (concentration (mM))
Further dilutions were also prepared using the Charles equation:
C1 x V1 = C2 x V2
C1 = concentration of stock solution
V1 = volume of stock solution
C2 = concentration of the solution to be prepared
V2 = volume of C2 of the solution to be prepared
Required dilutions and fresh stock solutions were all prepared fresh before the start
of experiments.
3.5 Electrophysiological recording
The two-electrode voltage clamp technique is a widely used method. It measures
the electric current generated by the flow of ions across the cell membrane while
clamping the trans-membrane potential at a specific value (in our experiments usually
-70 mV). This is done by using a feedback amplifier. This technique allows the
evaluation of the functional properties of different proteins expressed in Xenopus
oocytes. The membrane potential (measured by the voltage sensing electrode and high
input resistance amplifier) is compared with a command voltage and the difference is
brought to zero by a feedback amplifier. The second electrode measures the total
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current generated by the amplifier to keep the oocyte at the clamped potential (Figure
3.7).

Figure 3.7: Illustration of electrical circuitry connecting oocytes to the recording setup (Schematic Diagram)
The oocytes were transferred to the perfusion chamber and bathed in ND96 solution
at a perfusion rate of 5-7 mL/minute (Figure 3.2). Prior to each experiment, two glass
microelectrodes were prepared by a vertical puller (David Kopf Instruments Tujunga,
CA, USA) and the animal pole (the dark side) was impaled by the two glass
microelectrodes filled with 3M KCL solution with a resistance of 1-2 MΩ. Drugs
were applied by a micropipette placed about 2 mm away from the oocytes, and
operated by gravity flow based multichannel application system. Two-electrode
voltage clamp was performed using a Geneclamp 500 amplifier (Axon Instruments,
Molecular Devices, Inc, Sunnyvale, CA, USA) that was interfaced to a PC computer
equipped with data acquisition software (Win WCP, University of Strathclyde,
Glasgow, UK).
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3.6 Tested electrophysiological parameters
αβ and α Thujone purchased from Sigma Aldrich were dissolved in absolute
Ethanol to prepare a 100 mM stock solution. Further final dilutions were prepared
using distilled water. Working dilutions of drug perfusion and ND96 must not
contain Ethanol concentrations of more than 0.3% (v/v) for the nAChRs because
our published results indicate that concentrations of Ethanol higher than 0.3%
interferes with the function of nicotinic receptors.
3.6.1

Concentration response curves

Acetylcholine (ACh) was selected as it is the endogenous agonist of nicotinic
receptors. Furthermore, ACh has less desensitizing properties on nAChRs compared
with other agents like nicotine.
Control readings of ACh induced currents (3-5 recording) at 5 min intervals were
obtained followed by wash out with regular ND96 solutions. The average of 3 or 4
readings were calculated and recorded as the control. Subsequently, the oocytes were
perfused for a total of 15 minutes with the selected concentrations of Thujone. The
average of two to three responses at the end of the 15 min drug application were
calculated to determine the effect of Thujone co-application with ACh. Finally, drug
perfusion was stopped and ND96 perfusion was restarted to record the recoveries of
ACh induced currents.
By comparing the maximum current amplitudes in the absence and presence of
Thujone, the percent inhibition of the drug was calculated. The values were
normalized and displayed as percent changes compared to controls. Using different
concentrations of Thujone, it was possible to construct dose response curves. For each
concentration of Thujone, averages of 5-6 oocytes were used.
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The concentration of Thujone that caused a 50 % inhibition of ACh-induced
currents (IC50) was calculated by nonlinear curve-fitting and regression fits (logistic
equation) using statistical software (Origin, OriginLab Corp., Northampton, MA,
USA).
3.6.2

Competitive and non-competitive inhibition

In this experiment, different concentrations of ACh, ranging from 1 µM to 1mM,
were used in the absence and presence of a fixed concentration of α-Thujone. Cells
were clamped at a holding potential of -70 mV using the GeneClamp500. An average
of 5-6 oocytes were used for each concentration and the percent inhibition was
recorded and calculated. Concentration response curves were plotted using computer
software (Origin, OriginLab Corp., Northampton, MA, USA).
3.6.3

Voltage dependency of drug inhibition

In these experiments, the membrane potential was held at different values ranging
from +20 mV to -120 mV for 30 seconds just before current recording to observe the
effect of drug at different membrane potentials. After each recording the potential was
returned back to -70 mV and the recordings were performed at 5 min intervals. The
ACh concentration was fixed at 100 µM at all tested holding potentials. The
relationship between voltage and current (I-V relationship) for the ACh induced
currents were determined in the absence and presence of α-Thujone.
3.6.4

Effect of Ca2+ on drug action

These experiments were conducted to determine the role of intracellular Ca2+ on αThujone inhibition of ACh induced currents. 50 nL of 100 mM stock solution of
BAPTA (1,2-bis (o-aminophenoxy) ethane-N, N, N’, N’-tetraacetic acid) was
injected into each oocyte just before the electrophysiological recording (Sands, Costa
and Patrick 1993b). Subsequently, the oocytes were kept in ND96 for 5-10 min and
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then transferred to ND96 solution containing 2 mM Ba2+ instead of Ca2+. The stock
solutions of BAPTA were prepared in distilled water and the pH was adjusted by
CsOH to 7.4 pH. The ND96 contained 1.8 mM BaCl2 instead of 1.8 mM CaCl2.
3.7 Statistical data analysis
Origin version 8.1 (Origin Lab Corp., Northampton, MA, USA) was used for
nonlinear curve fitting. The average values were calculated as the mean ± standard
error means (SEM). ANOVA or Student’s t-test was used for statistical analysis.
Specific p value of p≤0.05 was considered significant. Concentration response curves
were acquired by fitting the data to the logistic equation:
y = Emax / (1+ [x / EC50] n)
Emax = maximal response (Keverne & Ray, 2005)
x = drug concentration
y = response
EC50 = half the maximal concentration
n = slope factor (apparent Hill coefficient)

47

Chapter 4: Results
4.1 Effects of ACh and α-bungarotoxin on α7 nAChRs
The endogenous nAChR agonist ACh was used to activate the nicotinic
receptors. In oocytes injected with cRNA of human α7 nAChRs, the application of
100 µM of ACh for 3-4 seconds caused fast inward currents (Figure 4A, control
currents) indicating that ACh induced currents were mediated by a protein
synthesized by the injection of human α7 nAChRs. In line with these findings, the
bath application of ACh for 4 seconds did not elicit a response on the oocytes
injected with distilled water (Figure 4B).
In the same experiment, α-bungarotoxin which is a selective and potent
inhibitor of the α7 nAChRs obtained from snake venom was used to verify the
pharmacology of these receptors. ACh-induced currents were significantly
inhibited by 30 nM α-bungarotoxin (Figure 4A, 4B). The recoveries were slow and
incomplete during the washout period (Figure 4A, right panel).
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Figure 4.1: Control experiments demonstrating the functional characterization of
ACh induced currents. (Figure 4.1.A) Current traces of control 100 µM ACh (left
panel), after 10 minutes bath application of 30 nM α-bungaratoxin (middle panel)
and following 15 minute washout 100 µM ACh (right panel). Bars represent the
means of maximal amplitudes of effects of ACh-induced currents vs distilled water
injected oocytes and human α7 nAChR 50 ng cRNA injected oocytes are shown in
(Figure 4.1.B). The numbers of oocytes tested were represented for each group on
top of each bar (n) in (Figure 4.1.B). In oocytes injected with human α7 nAChR
cRNA, the mean maximal amplitudes of ACh-induced currents in the presence and
absence of α-bungaratoxin were presented on the right side of the (Figure 4.1.B)
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4.2

Time and Concentration effects of α-Thujone on α7 nAChR

The following experiments (Figure 4.2) involves the time and concentration effects
of α-Thujone on the α7 nAChR induced currents.
In the Figure 4.2.A the current traces show the effects of 100 µM ACh in control
conditions (left panel), followed by 10 minutes bath application of α-Thujone (100
µM) co-applied with Acetylcholine (100 µM) and finally the recovery after 15 min αThujone wash out (right panel).
Figure 4.2.B shows the time course of the effect and the recovery of α-Thujone
application, on the maximal amplitudes of currents induced by the application of 100
µM ACh for 15 min. Time course of the effect of vehicle (0.1% Ethanol; filled circles)
and α-Thujone (100 µM; open circles) on the maximal amplitudes of ACh induced
currents. Each data point represents the normalized mean ± S.E.M. of 6 - 8
experiments.
We have also investigated the time course of α-Thujone inhibition by comparing
various pre-incubation times of α-Thujone on ACh induced currents Figure 4.2.C.
The ACh induced currents in the presence of α-Thujone (co-application) without preincubation did not cause a significant change in the amplitudes of currents (as seen
before break sign on the X-axis) and the small augmentation of currents was not
statistically significant (P > 0.05 paired t-test. 6–7 oocytes). However, pre-incubation
of α-Thujone 100 µM before the (ACh + α-Thujone) co-application caused a
significant inhibition of the α7 nAChR mediated induced ion currents. The mean
inhibition as a function of α-Thujone pre-incubation times was presented in the figure
after the break sign on the X-axis and ultimately, the half maximal inhibition or (τ1/2)
was calculated to be 1.4 ± 1 min (n= 6-7 oocytes). Usually in our experiments and
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the majority of the time we pre-incubated with α-Thujone before co-application for
10 - 15 min to ensure equilibrium conditions.
Figure 4.2.D. demonstrates the concentration-response curve for α-Thujone.
Increasing the concentrations of α-Thujone caused further decrease in the amplitudes
of 100 µM ACh-induced currents and shows that α-Thujone inhibited the α7 nAChR
function in a concentration dependent manner with an IC50 of 24.7 µM.

Figure 4.2: Effects of α-Thujone on α7 nAChR: (A) Records of currents activated
by 100 µM ACh in control conditions (left panel), after 10 min pre-treatment with
100 µM α-Thujone co-application (middle panel), and 15 min washout (right
panel). (B) Time-course of the effect of vehicle (0.1% Ethanol; filled circles) and αThujone (100 µM open circles) on the maximal amplitudes of ACh induced
currents. Each data point represents the normalized mean ± S.E.M. of 6 – 8
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experiments. The horizontal bar represents the application duration of both the
Vehicle and α-Thujone. (C) The effect of pre-application of α-Thujone. Increased
pre-application time significantly increased the inhibition of α7-nACh receptors.
Each data point represents the mean ± S.E.M. of 6 – 7 oocytes. (D) The
concentration dependence time course of α-Thujone inhibition. Each data point
represents the mean ± S.E.M. of 6 – 9 oocytes. The curve is best fit of the data to
the logistic equation described in the methods section.
4.3 Effects of α-Thujone on endogenous Ca2+ dependent Cl- Channels and
voltage dependence
In order to understand the mechanisms involved in α-Thujone’s inhibition,
further investigations were conducted on α7-nAChRs. It has been shown in previous
studies that the α7-nAChRs have a high permeability for Ca2+ cations. Entrance of
Ca2+ through α7-nAChRs has been shown to activate endogenous Ca2+ dependent Clchannels (Sands et al., 1993; Seguela, Wadiche, Dineleymiller, Dani, & Patrick,
1993). In order to find whether α-Thujone acts on endogenous Ca2+ dependent Clchannels, we have recorded nAChR induced currents in Ca2+ free solution by
replacing Ca2+ in the extracellular solution with Ba2+ since Ba2+ can pass through the
receptors without activating these endogenous Ca2+ dependent Cl- channels (Sands et
al., 1993).
It has also been proposed by (Sands et al., 1993) that even when Ba2+ is present,
endogenous Ca2+ dependent Cl- channels are not completely eliminated. Therefore,
we have blocked the activity of these channels by the intracellular injection of
BAPTA (1,2-bis (o-aminophenoxy) ethane-N,N,N’,N’-tetraacetic acid) a Ca2+
chelating agent. Experiments were performed in BAPTA injected oocytes and
perfused with an extracellular solution of 2 mM Ba2+ instead of Ca2+ cations (Sands
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et al., 1993). The bath application of 100 µM α-Thujone caused the same level of
inhibition (80 ± 5 % in controls versus 78 ± 5 % in BAPTA injected oocytes;
ANOVA, P >0.05) on ACh induced currents when compared to BAPTA injected
oocytes recorded in 2 mM Ba2 (Figure 4.3A).
It is possible that the inhibition of receptors is altered by changes in membrane
potential. Therefore, we have investigated if the inhibition of α-Thujone was effected
by membrane potential. As shown in Figure 4.3B in the presence (circles) and
absence (filled circles) of 100 µM α-Thujone, ACh induced currents were recorded
and normalized to controls at different voltages from -120 mV to 0 mV. The
membrane potential was held at voltages between -120 and 0 mV for 30 seconds
before each current recording and returned to the holding potential of -70 mV. Figure
4.3C show the extent of α-Thujone induced inhibition at different voltages. The
results reveal that the inhibition of α-Thujone 100 µM was not changed by alterations
in membrane potential (P>0.05, n=6, ANOVA).
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Figure 4.3: Effects of α-Thujone on endogenous Ca2+ dependent Cl- Channels and
voltage dependence. In the presence of BAPTA, the effects of α-Thujone on α7nAChRs are not dependent on intracellular Ca2+ levels and changes in membrane
potential. The effects of 100 µM α-Thujone (10 min) on the maximal amplitudes of
ACh induced currents in oocytes injected with 50 nl distilled water controls (n=5) or
BAPTA (50 nl, 200 mM, n=6). Bars represent the means ± S.E.M. of 5 – 6
experiments. (B) Current-voltage relationship of ACh induced currents in the absence
and presence of α-Thujone. Normalized currents activated by 100 µM ACh before
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(control, filled circles) and after 10 min treatment with 100 µM α-Thujone (open
circles). Each data point presents the normalized means ± S.E.M. of 5 – 6
experiments. (C) Quantitative presentation of the effect of α-Thujone as percent
inhibition at different voltages. Each data point presents the normalized means ±
S.E.M. of 5 – 6 experiments.
4.4 Non-competitive effects of α-Thujone on α7 nAChR
Furthermore, we examined the possible sites mediating the effect of α-Thujone on
the α7-nAChRs. We investigated whether α-Thujone acts as a competitive or noncompetitive antagonist of these receptors. ACh induced concentration response
curves were plotted in the absence and presence of α-Thujone (Figure 4.4). The
maximum response induced by ACh was reduced to 30 ± 5% (n= 8-12), whereas the
EC50 values remained unchanged. (93±8 µM in controls versus 98±7 µM α-Thujone,
ANOVA, P>0.005, n=5-8). These results provide evidence that α-Thujone inhibits
the function of α7-nAChRs and ACh-induced currents in a non-competitive manner.

Figure 4.4: Concentration-response curve for α-Thujone during increasing
concentrations of ACh. Filled circles indicate the ACh induced currents. Open circles
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indicate the responses in the presence of α-Thujone. Responses are normalized to
maximal ACh induced currents. Each data point presents the normalized means ±
S.E.M. of 5 – 6 experiments.
4.5 Effects of Thujone Sterioisomers on α7 nAChR
Since Thujone has two major stereoisomers, we have investigated whether these
stereoisomers would behave differently on the human α7 nAChRs, so we compared
the percent of inhibition of both 100 µM α-Thujone and 100 µM αβ-Thujone (Figure
4.5). The level of inhibition of the current traces was similar for both compounds with
no statistical significance (ANOVA, P>0.05, n=5-6).

Figure 4.5: Percent of Inhibition of α-Thujone and αβ-Thujone on human α7-nAChRs
induced currents with 100 µM Acetylcholine. Each data point presents the
normalized means ± S.E.M. of 5 – 6 experiments.
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4.6 Effects of Thujone on different nAChRs
In the last set of experiments were compared. The effects of α-Thujone on different
subtypes of the nAChRs were compared. The level of inhibition between different
subtype combinations of nAChRs indicated that α-Thujone has the highest potency for
α7 nAChRs. Although α4β2 was also significantly inhibited, the extent of inhibition
by α-Thujone was significantly less than that of α7 nAChRs (Figure 4.6.)

Figure 4.6: Percent of inhibition of 100 µM α-Thujone co-applied with 100 µM ACh
on different nAChRs induced oocyte currents. Each data point presents the
normalized means ± S.E.M. of 5 – 6 experiments.
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Chapter 5: Discussion
The results of our study indicate that Thujone binds non-competitively to α7-nACh
receptors and causes time and concentration dependent inhibition.
In an earlier study the mechanism of Thujone neurotoxicity was investigated (Hold
et al., 2000). It was demonstrated that the poisoning signs of Thujone (and their
alleviation by diazepam and phenobarbital) in mice are similar to those of the classical
antagonist picrotoxin suggesting that GABAA receptors are involved in Thujone
toxicity. Secondly, a strain of Drosophila specifically resistant to chloride channel
blockers was found to be tolerant to Thujone. Third it was shown that Thujone is a
competitive inhibitor of a GABAA receptor ligand, [3H]ethynylbicycloorthobenzoate
binding to mouse brain membranes. In addition, peak currents induced by GABA in
rat dorsal root ganglion neurons are suppressed by Thujone with an IC50 value of 21
µM (Hold et al., 2000). The action of Thujone on GABAergic miniature inhibitory
post-synaptic currents (mIPSCs) and on responses to exogenous GABA applications
was also studied in cultured hippocampal neurons (Szczot et al., 2012). Thujone
reduced mIPSC frequency and amplitude and also moderately affected their kinetics,
indicating both pre- and postsynaptic mechanisms. Analysis of current responses to
exogenous GABA revealed that Thujone reduced their amplitude, affecting their onset,
desensitization, and deactivation, suggesting an effect on the gating of GABAA
receptors (Szczot et al., 2012). However, GABAA receptors are highly heterogeneous
and the effects of Thujone have also been investigated on different recombinant
GABAA receptors (α1β2γ2L, α1β2, α1β2δd and α4β2δ) relevant to phasic or tonic
forms of GABAA responses. It was shown that α-Thujone, in the concentration range
of 100 to 300 µM, inhibits all receptor subtypes by a qualitatively similar mechanism
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but the strongest effect was observed for α1β2δ receptors, suggesting that tonic
currents might be more sensitive to Thujone than the phasic ones. Moreover, tonic
currents, mimicked by response to a sub-µM GABA concentration (0.3 µM) in
cultured neurons, showed a substantially larger sensitivity to Thujone than responses
elicited by higher [GABA] (more similar to phasic currents) or inhibitory postsynaptic
currents in the same preparation. Importantly, the extent of tonic current inhibition by
α-Thujone was as strong as in the case of currents mediated by α1β2δ receptors.
Collectively, these data provide evidence that different GABAA receptor subtypes
show distinct sensitivities to α-Thujone and suggest that this compound may
differentially affect tonic and phasic components of GABAergic inhibition
(Czyzewska and Mozrzymas, 2013).
Studies on the neurotoxic actions of Thujone have also been extended to fear-anxiety
behaviors (Rivera et al., 2014). Higher doses of Thujone were convulsant by eliciting
a toxic and excitatory action. Their results showed that a dose of 78 nmol of Thujone
had an anxiogenic-like effect observed as an increased latency to ambulate and a
reduced locomotor activity in open field experiments. Nevertheless, only the central
administration of Thujone reversed the increase induced by acute stress in the
flunitrazepam-sensitive GABAA receptor recruitment. These findings demonstrated
that Thujone, when intracerebroventricularly administered, suppressed the GABAA
receptor recruitment induced by acute stress, may be due to Thujone blocking the
benzodiazepine binding site or another site of the GABAA complex (Rivera et al.,
2014).
The effects of α-Thujone have also been investigated on 5-HT3 receptors, another
member of ligand-gated ion channel family. In earlier studies (Deiml et al., 2004),
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patch-clamp experiments revealed an inhibitory action of Thujone on both homomeric
(5-HT3A) and heteromeric (5-HT3AB) 5HT3 receptors expressed in HEK-293 cells.
Their results indicated that in homomeric receptors, α-Thujone enhanced the inherent
channel-blocking potency of the natural ligand, 5-HT. The IC50 value for α-Thujone
was found to be 60 µM. On the other hand, in heteromeric receptors, α-Thujone
recruited an additional channel-blocking component of the agonist. It was suggested
that α-Thujone reduced 5-HT3 receptor activity by an effect on mechanisms involved
in receptor desensitization, which depend on receptor subunit composition.
Although, the α7 nAChRs are known to cause an increase in the intracellular Ca2+
levels and to activate endogenous Ca2+ dependent Cl- channels, our results indicate
that α-Thujone does not activate these channels indicating that the effects of α-Thujone
observed in our experiments are not due to its effects on these channels.
In addition, α-Thujone was able to bind and inhibit the α7 nAChRs in a noncompetitive manner. Our results show that even high concentrations of ACh cannot
reverse the inhibitory effect of α-Thujone, indicating that α-Thujone does not compete
with ACh. α-Thujone is a monoterpene ketone, and these compounds have highly
volatile and non-polar (lipophilic) structures that usually allow high membrane
penetration (Clarke, 2008a). Considering the relatively slow onset of α-Thujone action
(τ=1.4 min), lack of voltage-dependency, and the non-competitive nature of α-Thujone
inhibition the results suggest that a hydrophobic binding site located in transmembrane
domains of nAChR is likely to mediate the effects of α-Thujone on nAChRs.
Monoterpenes such as Thujone possess variable basic skeletons and exhibit
stereoisomerism. It has also been shown that some of the biological effects of
monoterpenes (Clarke, 2008b) and Thujone (Rivera et al., 2014) show stereo specific
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action in in-vitro studies. However, our results indicate that α-Thujone and the racemic
αβ-Thujone (β-Thujone is commercially unavailable) caused similar extents of
inhibition suggesting that the effect of Thujone does not require stereospecific binding
for its inhibitory actions in-vitro, because in-vivo models could behave differently.
Cholinergic nAChRs are involved in the pathogenesis of several diseases such as
Alzheimer disease (AD), myasthenia gravis (MG), neuro-inflammation, and nicotine
addiction (Gotti & Clementi, 2004; Keverne & Ray, 2005; Mufson et al., 2009). The
results of these studies have not been conclusive possibly because more types of
nAChRs are involved (for a review; Oz et al., 2013). In these studies, both inhibition
and activation of nAChRs have been linked to pro-cognitive and pro-inflammatory
effects. Many compounds such as Acetylcholinesterase AChE Inhibitors such as:
Galantamine, Donepezil and Tacrine also target the same α7 nAChRs with actions of
both stimulation and inhibition (Keverne & Ray, 2005). Other drugs involved in AD
such as Memantine have also been reported to cause an inhibition on the α7 nAChRs
(Eglen et al., 2001; Gangadhar, Mishra, Sriram, & Yogeeswari, 2014; Keverne & Ray,
2005).
Finally, in addition to α7-nAChR, other nicotinic receptors such as: α4β2, α3β2,
α3β4 and α4β4 have been shown to be expressed in both the central and peripheral
nervous systems. Therefore, we have investigated the effect of Thujone on these
receptor subtypes. Our results indicated that, compared to other nAChR tested in our
study, Thujone acted most potently on α7-nAChR suggesting that the effects of
Thujone are somewhat specific to α7-nAChR.
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Chapter 6: Conclusion
This study provides the first evidence for the effects of Thujone on different
nAChRs, such as α7, α4β2 α3β2, α3β4 and α4β4. The study suggests that these
receptors have pharmacologically different sensitivities to α-Thujone. Although α4β2
receptors were inhibited by 100 µM α-Thujone, the potency of Thujone on α7-nAChRs
were significantly higher than α4β2 receptors. Inhibition by α-Thujone was
concentration dependent with IC50 of 24.7 µM. It appears that α-Thujone acts as a noncompetitive antagonist on the α7 nAChRs. The effect of α-Thujone is not voltage
dependent and does not involve endogenous Ca2+ dependent Cl- channels. There is no
significant difference between α-Thujone and αβ-Thujone racemic mixtures regarding
the extent of its inhibitory effect on nAChR. In conclusion, our results suggest that
Thujone inhibits nAChRs and could lead to the development of new compounds
effecting these receptors.
6.1

Limitations and Future directions:

In this study, we did not examine the effects of Thujone on mammalian cell
lines and native neurons. It is possible that post-translational modification in Xenopus
oocytes are different from mammalian cell lines. In future studies we could study the
effects of Thujone on nicotinic receptors expressed in mammalian cell lines.
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